Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.77B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.52B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.18B |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$947M |
| 5 |
Zoetis
ZTS
|
+$787M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.39B |
| 2 |
NVIDIA
NVDA
|
+$2.32B |
| 3 |
Microsoft
MSFT
|
+$2.06B |
| 4 |
Apple
AAPL
|
+$1.62B |
| 5 |
Vanguard Total Bond Market
BND
|
+$1.51B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.47% |
| 2 | Financials | 11.66% |
| 3 | Consumer Discretionary | 8.63% |
| 4 | Communication Services | 7.31% |
| 5 | Healthcare | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Kiniksa Pharmaceuticals
KNSA
$5.8B
| $29.5M | ﹤0.01% |
1,066,279
-10,120
| -0.9% | -$258K |
|
2427
Strategic Education
STRA
$1.85B
| $29.5M | ﹤0.01% |
346,048
+86,171
| +33% | +$7.32M |
|
|
AIO
2428
Virtus Artificial Intelligence & Technology Opportunities Fund
AIO
$869M
| $29.4M | ﹤0.01% |
1,186,537
+9,385
| +0.8% | +$207K |
|
2429
Visteon
VC
$2.79B
| $29.4M | ﹤0.01% |
314,795
-4,296
| -1% | -$353K |
|
2430
Viavi Solutions
VIAV
$9.12B
| $29.4M | ﹤0.01% |
2,915,632
+242,453
| +9% | +$2.34M |
|
2431
State Street SPDR US Large Cap Low Volatility Index ETF
LGLV
$1.2B
| $29.3M | ﹤0.01% |
168,069
-138
| -0.1% | -$23.6K |
|
2432
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.54B
| $29.2M | ﹤0.01% |
1,059,317
+43,872
| +4% | +$1.12M |
|
2433
ROBO Global Robotics & Automation Index ETF
ROBO
$1.96B
| $29.1M | ﹤0.01% |
487,383
-32,653
| -6% | -$1.75M |
|
2434
HNI Corp
HNI
$3.24B
| $29.1M | ﹤0.01% |
591,478
-9,977
| -2% | -$452K |
|
2435
Triple Flag Precious Metals
TFPM
$5.94B
| $29M | ﹤0.01% |
1,226,024
+444,424
| +57% | +$9.74M |
|
2436
ICF International
ICFI
$1.46B
| $29M | ﹤0.01% |
342,843
+58,654
| +21% | +$4.97M |
|
2437
Invesco DB Commodity Index Tracking Fund
DBC
$1.69B
| $29M | ﹤0.01% |
1,330,129
-262,123
| -16% | -$5.62M |
|
2438
WisdomTree US High Dividend Fund
DHS
$1.56B
| $29M | ﹤0.01% |
302,065
-3,477
| -1% | -$326K |
|
2439
Crane NXT
CXT
$2.99B
| $29M | ﹤0.01% |
537,304
+118,647
| +28% | +$6.04M |
|
2440
Fidelity MSCI Health Care Index ETF
FHLC
$3.28B
| $28.9M | ﹤0.01% |
452,493
+21,585
| +5% | +$1.37M |
|
2441
Par Pacific Holdings
PARR
$4.31B
| $28.9M | ﹤0.01% |
1,089,714
+267,541
| +33% | +$5.1M |
|
2442
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$429M
| $28.9M | ﹤0.01% |
340,583
-23,860
| -7% | -$1.89M |
|
2443
Azenta
AZTA
$1.3B
| $28.9M | ﹤0.01% |
938,443
+353,478
| +60% | +$9.95M |
|
2444
Chemours
CC
$2.5B
| $28.9M | ﹤0.01% |
2,521,301
+691,268
| +38% | +$7.79M |
|
2445
LiveRamp
RAMP
$2.3B
| $28.9M | ﹤0.01% |
873,416
-143,855
| -14% | -$4.18M |
|
2446
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.62B
| $28.9M | ﹤0.01% |
574,641
-70,746
| -11% | -$3.46M |
|
2447
Mirum Pharmaceuticals
MIRM
$6.46B
| $28.8M | ﹤0.01% |
566,326
-40,105
| -7% | -$1.79M |
|
|
YSG
2448
Yatsen Holding
YSG
$322M
| $28.8M | ﹤0.01% |
2,987,590
+1,006,909
| +51% | +$5.77M |
|
2449
Neuropace
NPCE
$439M
| $28.8M | ﹤0.01% |
2,585,073
+54,453
| +2% | +$681K |
|
2450
Recursion Pharmaceuticals
RXRX
$1.59B
| $28.8M | ﹤0.01% |
5,689,612
+679,179
| +14% | +$3.34M |
|
Similar funds
Morgan Stanley's Q2 2025 Portfolio in Review
As of Q2 2025, Morgan Stanley held 8,401 positions worth $1.54T, up 9.8% from $1.4T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2025 filing shows 313 new, 3,923 increased, 2,951 reduced and 306 closed positions. Its largest new stake was JBS N.V.: 7,554,358 shares worth $110M. The largest sale was UnitedHealth, an estimated $2.39B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q2 2025 buy was JBS N.V.: 7,554,358 shares worth $110M.
- Morgan Stanley added most to Vanguard Short-Term Bond ETF in Q2 2025, an estimated $1.77B increase.
- Morgan Stanley's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $2.39B.
- Morgan Stanley fully exited Discover Financial Services in Q2 2025, selling an estimated $786M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.54T portfolio in Q2 2025.
- Morgan Stanley opened 313 new positions and closed 306 in Q2 2025.
- Morgan Stanley's portfolio value rose 9.8% quarter-over-quarter to $1.54T.
Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.